Google Übersetzer
Ardelyx, Inc.
About
6.17USD-0.10 -1.59%
Closed • Updated at 13:55 GMT+00:00Market Cap$1.52B
Volume148.3K
Beta1.64
RSI44.88
Gross Margin91.72%
Ardelyx, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
Apr 30 2026
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
Apr 27 2026
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
Apr 23 2026
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Apr 20 2026
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer